Skip to content

CTEV CTEV Net Change in Cash

Net Change in Cash at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$3.64B-32.7%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$11.95M-112%
Corvel logo
CorvelCRVL
$3.04M-60.2%
ROP
Roper Technologies, Inc.ROP
$85.5M-53.7%
Cognizant logo
CognizantCTSH
-$1.13B-350%
Phreesia logo
PhreesiaPHR
$2.57M-61.4%

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's net change in cash?
CTEV (CTEV) reported net change in cash of $6.39M in Q1 2026.
How has CTEV's net change in cash changed year-over-year?
CTEV's net change in cash increased by 51.1% year-over-year, from $4.23M to $6.39M.
What is the long-term trend for CTEV's net change in cash?
Over 2 years (2023 to 2025), CTEV's net change in cash has grown at a -93.0% compound annual growth rate (CAGR), from -$270.79M to -$1.33M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.